纤维蛋白原耗竭性凝血病预测缺血性卒中溶栓后大出血:一项多中心研究
这项多中心前瞻性观察队列研究纳入1678例接受静脉溶栓的急性缺血性卒中患者,在基线、溶栓后2小时和6小时评估纤维蛋白原浓度。纤维蛋白原耗竭是症状性颅内出血(OR 1.55)和大出血(OR 1.36)的显著预测因素,31%的症状性颅内出血可归因于纤维蛋白原耗竭。
要点
- 纤维蛋白原耗竭是静脉溶栓后症状性颅内出血的独立危险因素(OR 1.55)。
- 纤维蛋白原耗竭是大出血的独立危险因素(OR 1.36)。
- 31%的症状性颅内出血可归因于纤维蛋白原耗竭。
核心结论
- 纤维蛋白原耗竭显著增加急性缺血性卒中静脉溶栓后症状性颅内出血和大出血的风险。
- 纤维蛋白原耗竭是出血的独立危险因素,可考虑常规评估以对颅内出血风险进行分层。
- 需要开展早期补充纤维蛋白原的试验以研究减轻出血风险。
研究设计与样本
- 多中心观察性前瞻性队列研究,纳入6个意大利中心连续接受静脉溶栓的急性缺血性卒中患者1678例。
- 在基线、溶栓后2小时和6小时评估纤维蛋白原浓度。
- 纤维蛋白原耗竭定义为溶栓后2小时纤维蛋白原降至200 mg/dL以下,或溶栓后2小时降至基线水平的50%以下。
主要发现
- 共纳入1678例患者,平均年龄72岁,46%为女性。
- 症状性颅内出血(n=116)和大出血(n=297)与较低的良好功能恢复率相关(P<0.001)。
- 尽管入院时纤维蛋白原水平相似,溶栓后2小时纤维蛋白原耗竭在症状性颅内出血、大出血及所有其他出血结局的患者中更常见。
- 在多因素logistic回归后退法模型中,纤维蛋白原耗竭仍是症状性颅内出血的显著预测因素(OR 1.55,95%CI 1.04-2.32)和大出血的显著预测因素(OR 1.36,95%CI 1.03-1.8)。
- 31%的症状性颅内出血可归因于纤维蛋白原耗竭;纤维蛋白原耗竭与卒中后3个月较差临床结局的关联(P=0.012)归因于大出血/症状性颅内出血风险较高。
关键数值与推荐
- 症状性颅内出血采用美国国立神经疾病和卒中研究所(NINDS)标准。
- 大出血定义为致命性出血、血红蛋白水平下降>2 g/dL/>1单位输血或关键部位出血。
- 其他结局包括任何颅内出血、任何出血、致命性颅内出血及根据ECASSII定义的症状性颅内出血。
- 良好功能恢复定义为3个月时改良Rankin量表评分0至2分。
临床怎么用
- 作者认为,纤维蛋白原耗竭是出血的独立危险因素,可考虑常规评估以对颅内出血风险进行分层。
- 作者认为,需要开展早期补充纤维蛋白原的试验以研究减轻出血风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Symptomatic intracerebral hemorrhage (sICH) and major bleeding can be fatal complications of intravenous thrombolysis (IVT) for acute ischemic stroke. We investigated the impact of early fibrinogen depletion after IVT on major bleeding events. METHODS: This multicenter observational prospective cohort study enrolled 1678 consecutive patients receiving IVT for acute ischemic stroke at 6 Italian centers, undergoing fibrinogen concentration assessment at baseline, 2 hours and 6 hours after IVT. Fibrinogen depletion was defined as a reduction below 200 mg/dL after 2 hours from IVT, or as a reduction below 50% of baseline fibrinogen levels after 2 hours from IVT. Main outcomes were (1) sICH (National Institute of Neurological Disorders and Stroke criteria) and (2) major bleeding defined as fatal bleeding, decrease in the hemoglobin level>2 g/dL/>1 unit transfusion, or bleeding at critical site. Additional outcomes were (1) any ICH, (2) any bleeding, (3) fatal ICH, and (4) sICH according to ECASSII definition. Good functional recovery was defined as modified Rankin Scale score 0 to 2 at 3 months. RESULTS: Overall, 1678 patients were included (mean age 72 years, 46% female). sICH (n=116) and major bleeding (n=297) were associated with lower rate of good functional recovery (P<0.001). Despite similar fibrinogen levels at admission, fibrinogen depletion after 2 hours from IVT was more common in people with sICH, major bleeding and all additional bleeding outcomes. In the backward stepwise multivariable logistic regression model, fibrinogen depletion remained a significant predictor of sICH (OR, 1.55 [95% CI, 1.04-2.32]) and major bleeding (OR, 1.36 [95% CI, 1.03-1.8]). Thirty-one percent of sICH could be attributable to fibrinogen depletion. The association between fibrinogen depletion and worse clinical outcome at 3 months after stroke (P=0.012) was attributable to the higher risk of major bleeding/sICH. CONCLUSIONS: Fibrinogen depletion significantly increases the risk of sICH and major bleeding after IVT for acute ischemic stroke. Fibrinogen depletion represents an independent risk factor for bleeding, and routine assessment could be considered to stratify the risk of ICH. Trials on early fibrinogen repletion are needed to investigate mitigation of bleeding risk.
引用
- Romoli M, Vandelli L, Bigliardi G, et al. Fibrinogen Depletion Coagulopathy Predicts Major Bleeding After Thrombolysis for Ischemic Stroke: A Multicenter Study. Stroke. 2022. PMID: 36039754. doi:10.1161/STROKEAHA.122.039652
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。